Skip to content
Smart Money

Pharmaceuticals

BFBIO BF Biosciences Limited

Latest results: FY2026 · Jun 2026

Last close · 16 Oct 2026

Rs 128.65 -0.96%

Quarterly · Q4 FY2023 – Q4 FY2026

BF Biosciences Limited (BFBIO) quarterly cash flow statement

BFBIO cash flow statement (quarterly) (Rs mn)
Rs mn TTM to Jun 2026 Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023 Q4 FY2023 Apr – Jun 2023
Operating activities
Profit (cash-flow starting line, as reported) — — 202.4 448.7 159.5 126.8 124.5 80.5 115.3 (104.2) 160.9 52.4 100.8 79.8
Depreciation & amortisation — — 69.4 68.7 67.4 65.1 80.8 32.2 15.5 10.8 8.4 8.4 8.5 8.7
Net cash from operating activities — — (831.5) 592.2 24.2 521.2 (428.3) 169.3 20.3 (6.2) 260.2 60.2 208.3 6.4
Investing activities
Capital expenditure — — (142.5) (176.5) (64.3) (130.6) (14.7) (92.0) (97.3) (36.9) (46.6) (34.2) (25.5) (65.9)
Net cash from investing activities — — 667.8 (238.8) (163.9) (283.8) 767.9 (1,813.9) (100.3) (38.5) (43.7) (35.6) 84.7 178.7
Financing activities
Borrowings raised / (repaid) — — (72.0) (149.7) (71.3) (190.8) (29.7) (95.5) (26.6) (120.2) (50.7) (101.5) (49.0) (3.6)
Net cash from financing activities — — (72.0) (149.7) (71.3) (190.8) (29.7) 107.7 1,625.4 (120.2) (50.7) (101.5) (49.0) (3.6)
Net change in cash — — (235.7) 203.7 (211.0) 46.7 309.9 (1,536.9) 1,545.4 (164.9) 165.7 (76.8) 244.0 181.6
Key figures
Free cash flow (operating cash flow − capex) — — (974.0) 415.7 (40.1) 390.6 (443.0) 77.3 (76.9) (43.1) 213.6 26.0 182.9 (59.5)
BFBIO cash flow statement — year-on-year change (Rs mn)
Rs mn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023 Q4 FY2023 Apr – Jun 2023
Operating activities
Profit (cash-flow starting line, as reported) — +62.5% +457.1% +38.4% — -22.6% +53.7% +14.4% -230.6% — — — —
Depreciation & amortisation — -14.1% +113.6% +335.7% +503.3% +860.1% +284.0% +81.4% +23.4% — — — —
Net cash from operating activities — — +249.8% +18.8% — -264.6% +181.1% -90.2% -196.8% — — — —
Investing activities
Capital expenditure — +871.3% +91.7% -33.9% +254.4% -68.5% +169.1% +281.8% -44.0% — — — —
Net cash from investing activities — -13.0% — — — — — -218.4% -121.5% — — — —
Financing activities
Borrowings raised / (repaid) — — — — — — — — — — — — —
Net cash from financing activities — — -239.0% -104.4% — — — — — — — — —
Net change in cash — -176.1% — -113.7% — +87.0% — +533.4% -190.8% — — — —
Key figures
Free cash flow (operating cash flow − capex) — — +438.1% — — -307.4% +196.9% -142.1% — — — — —

Change against the same quarter a year earlier; shown when the earlier figure is positive.

Figures in Pakistani rupees as reported by the company; costs and cash outflows in brackets; "—" = not reported. TTM = the latest four quarters added together. Updated 16 Oct 2026.

All reported line items 52
BFBIO cash flow statement — all reported line items (Rs mn)
Rs mn Q4 FY2026 Apr – Jun 2026 Q3 FY2026 Jan – Mar 2026 Q2 FY2026 Oct – Dec 2025 Q1 FY2026 Jul – Sep 2025 Q4 FY2025 Apr – Jun 2025 Q3 FY2025 Jan – Mar 2025 Q2 FY2025 Oct – Dec 2024 Q1 FY2025 Jul – Sep 2024 Q4 FY2024 Apr – Jun 2024 Q3 FY2024 Jan – Mar 2024 Q2 FY2024 Oct – Dec 2023 Q1 FY2024 Jul – Sep 2023
Profit/(Loss) - Starting Line - Cash Flow — 202.4 448.7 159.5 126.8 124.5 80.5 115.3 (104.2) 160.9 52.4 100.8
Non-cash Items & Reconciliation Adjustments - Cash Flow — 115.6 1.9 190.6 121.5 130.5 104.4 130.4 239.0 130.7 75.3 116.5
Income Tax Expense - Cash Flow - to Reconcile — — (108.4) 108.4 71.6 75.2 60.3 66.3 190.2 71.1 34.0 62.0
Other Non-Cash Items & Reconciliation Adjustments - Cash Flow - to Reconcile — 45.3 50.0 23.0 17.0 (16.1) 4.0 16.0 5.8 21.1 (1.3) 14.3
Financial Income/(Expense) - Cash Flow - to Reconcile — 22.5 24.4 24.7 (75.2) 29.7 39.8 34.7 32.1 30.4 34.3 33.7
Depreciation, Depletion & Amortization including Impairment - Cash Flow - to Reconcile — 69.4 68.7 67.4 65.1 80.8 32.2 15.5 10.8 8.4 8.4 8.5
Depreciation & Depletion - Property, Plant & Equipment - Cash Flow - to Reconcile — 69.0 68.3 67.0 64.6 80.3 31.8 15.3 10.7 8.3 8.2 8.4
Amortization - Intangible Assets & Deferred Charges - Cash Flow - to Reconcile — 0.4 0.4 0.4 0.6 0.6 0.4 0.1 0.1 0.1 0.1 0.1
Assets Sale - Gain/(Loss) - Cash Flow - to Reconcile — (37.1) (15.4) (3.1) 0.8 (28.5) (0.1) 0.0 0.0 (0.4) (0.0) (2.1)
Financial Assets - Unrealized Gain/(Loss) - Cash Flow - to Reconcile — 15.4 (17.5) (29.8) 42.2 (10.7) (31.7) (2.0) 0.1 0.0 (0.1) 0.1
Income Taxes - Paid/(Reimbursed) - Cash Flow — 76.2 73.5 82.1 71.6 30.1 163.3 14.0 17.2 11.6 6.9 11.1
Interest Paid - Cash — 12.9 22.8 23.8 14.0 26.3 36.8 35.1 34.4 36.6 43.9 46.7
Interest & Dividends - Received - Total - Cash Flow — 0.6 3.5 1.6 76.5 0.4 17.8 0.4 3.4 5.4 2.9 7.6
Cash Flow from Operating Activities before Changes in Working Capital — 229.4 357.8 245.9 239.2 198.9 2.6 197.0 86.5 248.9 79.9 167.2
Working Capital - Increase/(Decrease) - Cash Flow — (1,060.9) 234.4 (221.7) 282.0 (627.2) 166.7 (176.7) (92.7) 11.3 (19.7) 41.2
Accounts Receivables - Decrease/(Increase) - Cash Flow — (26.5) (28.3) (503.0) 225.8 (131.9) 162.9 (307.3) 75.0 (165.9) (1.4) (30.5)
Inventories - Decrease/(Increase) - Cash Flow — (65.0) (923.2) (49.5) 96.2 (353.3) (347.1) (242.2) (29.0) 19.4 59.7 (91.6)
Other Assets - Decrease/(Increase) - Cash Flow — 105.8 (82.2) 41.5 (17.0) (36.6) 246.0 (117.7) (44.9) 11.4 (33.1) (45.6)
Accounts Payable and Accrued Expenses - Increase/(Decrease) - Cash Flow — (965.8) 1,166.7 274.0 (13.1) (89.2) 100.2 474.6 (87.9) 177.6 (87.1) 194.2
Other Liabilities - Increase/(Decrease) -Total - Cash Flow — (109.5) 101.4 15.3 (9.8) (16.2) 4.7 16.0 (5.9) (31.2) 42.2 14.6
Net Cash Flow from Operating Activities — (831.5) 592.2 24.2 521.2 (428.3) 169.3 20.3 (6.2) 260.2 60.2 208.3
Capital Expenditures - Net - Cash Flow — 138.9 173.6 64.3 123.7 12.8 91.9 97.3 36.9 42.2 34.2 25.5
Property, Plant & Equipment - Purchased/(Sold) - Net - Cash Flow — 138.9 173.6 64.3 128.8 7.7 91.9 97.3 36.9 42.2 34.2 25.5
Property, Plant & Equipment - Purchased - Cash Flow — 142.5 176.5 64.3 130.6 9.6 92.0 97.3 36.9 46.6 34.2 25.5
Property, Plant & Equipment Sold - Cash Flow — 3.6 2.8 0.0 1.8 1.8 0.2 — — 4.4 — —
Intangible Assets - Purchased/(Sold) - Net - Total - Cash Flow — — — — (5.1) 5.1 — — 0.0 — — —
Intangible Assets - Purchased/Acquired - Cash Flow — — — — — 5.1 — — 0.0 — — —
Intangible Assets - Net - Cash Flow — — — — (5.1) — — — — — — —
Capital Expenditures - Total — 142.5 176.5 64.3 130.6 14.7 92.0 97.3 36.9 46.6 34.2 25.5
Investments excluding Loans - Decrease/(Increase) - Cash Flow — 805.9 0.8 (99.6) (156.1) 780.7 (1,725.0) — (1.6) (1.5) (1.4) 113.1
Investment Securities - Unclassified - Sold/(Purchased) - Net - Total - Cash Flow — 805.9 0.8 (99.6) (156.1) 780.7 (1,725.0) — (1.6) (1.5) (1.4) 113.1
Other Investing Cash Flow - Decrease/(Increase) — 0.8 (66.0) — (4.0) (0.0) 3.0 (3.0) — 0.0 0.0 (3.0)
Net Cash Flow from Investing Activities — 667.8 (238.8) (163.9) (283.8) 767.9 (1,813.9) (100.3) (38.5) (43.7) (35.6) 84.7
Debt - Long-Term & Short-Term - Issuance/(Retirement) - Total - Cash Flow — (72.0) (149.7) (71.3) (190.8) (29.7) (95.5) (26.6) (120.2) (50.7) (101.5) (49.0)
Debt - Issued/Reduced - Long-Term - Cash Flow — (72.0) (149.7) (71.3) (190.8) (29.7) (95.5) (26.6) (120.2) (50.7) (101.5) (49.0)
Debt - Issued - Long-Term - Cash Flow — 0.0 0.0 0.0 0.0 0.0 66.8 26.8 0.0 0.0 0.0 0.0
Debt - Reduced - Long-Term - Cash Flow — 72.0 149.7 71.3 190.8 29.7 162.3 53.4 120.2 50.7 101.5 49.0
Other Financing Cash Flow - Increase/(Decrease) — 0.0 0.0 0.0 0.0 0.0 203.2 1,652.0 — 0.0 0.0 0.0
Net Cash Flow from Financing Activities — (72.0) (149.7) (71.3) (190.8) (29.7) 107.7 1,625.4 (120.2) (50.7) (101.5) (49.0)
Net Change in Cash - Total — (235.7) 203.7 (211.0) 46.7 309.9 (1,536.9) 1,545.4 (164.9) 165.7 (76.8) 244.0
Net Cash from Continuing Operations — (235.7) 203.7 (211.0) 46.7 309.9 (1,536.9) 1,545.4 (164.9) 165.7 (76.8) 244.0
Net Cash - Beginning Balance — 307.7 104.1 315.1 268.4 (41.4) 1,495.5 (49.9) 114.9 (50.8) 26.0 (217.9)
Net Cash - Ending Balance — 72.1 307.7 104.1 315.1 268.4 (41.4) 1,495.5 (49.9) 114.9 (50.8) 26.0
Income Taxes - Paid/(Reimbursed) - Cash Flow - Supplemental — 76.2 73.5 82.1 71.6 30.1 163.3 14.0 17.2 11.6 6.9 11.1
Interest Paid - Cash Flow - Supplemental — 12.9 22.8 23.8 14.0 26.3 36.8 35.1 34.4 36.6 43.9 46.7
Interest & Dividends - Received - Cash Flow - Supplemental — 0.6 3.5 1.6 76.5 0.4 17.8 0.4 3.4 5.4 2.9 7.6
CF from Optg Activities before Change in WC & Int Payments — 242.4 380.6 269.7 253.3 225.2 39.4 232.1 121.0 285.4 123.8 213.8
Contract Liabilities - Increase/(Decrease) - Cash Flow — (109.5) 101.4 15.3 (9.8) (16.2) 4.7 16.0 (5.9) (31.2) 42.2 14.6
Depreciation, Depletion & Amortization - Cash Flow — 69.4 68.7 67.4 65.1 80.8 32.2 15.5 10.8 8.4 8.4 8.5
Free Cash Flow to Equity — (1,042.4) 268.8 (111.4) 206.8 (470.8) (18.1) (103.6) (163.2) 167.2 (75.4) 133.8
Free Cash Flow Net of Dividends — (974.0) 415.7 (40.1) 390.6 (443.0) 77.3 (76.9) (43.1) 213.6 26.0 182.9
Free Cash Flow — (974.0) 415.7 (40.1) 390.6 (443.0) 77.3 (76.9) (43.1) 213.6 26.0 182.9

Every line the company reported, in the original order and wording, without regrouping or signs changed. Latest 12 periods; the table above goes back further.